Get started
Author

Jinmeng Li

Observed institution: Beijing University of Technology
ORCID: 0000-0002-7613-9506
Observed ORCID: 0000-0002-7613-9506
OpenAlex ID: A5091274780
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer
2023 · Huina Wang, Bo Liu, et al. · iScience · 12
PDF
Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle
2023 · Xujie Zhuang, Bo Liu, et al. · Clinical & Translational Oncology · 6
Four‐gene signature based on machine learning filtration could predict prognosis of patients with breast cancer
2022 · Bo Liu, Huina Wang, et al. · Expert Systems · 2
Integrative analysis identifies three molecular subsets in ovarian cancer
2022 · Bo Liu, Xinchan Ji, et al. · Clinical and Translational Medicine · 2
PDF
A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer
2022 · Bo Liu, Nian Zhu, et al. · Journal of Oncology · 1
PDF
Comprehensive analysis of molecular characteristics between primary and breast-derived metastatic ovarian cancer
2025 · Junqi Long, Bo Liu, et al. · Translational Cancer Research
Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitor for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer: A Case Report
2024 · Huaichong WANG, Liujie Gao, et al. · SSRN Electronic Journal
Works count: 7
Citation count: 23
H-index: 2
I10-index: 1
Year
Topic
Type